[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
300
about 23 years
All ages
Male only
7 sites in NJ, NY
What this study is about
Researchers are testing whether [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone PET scans can help find prostate cancer that has spread. The trial will involve men with advanced prostate cancer who have not responded to other treatments. This treatment involves a radiotracer, which is a type of x-ray test.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
hormone therapy (Androgen hormone; promotes male traits and muscle growth), BLOOD AND BLOOD FORMING ORGANS
oral (Oral Capsule)
Primary: To study the accumulation and biodistribution of FDHT in patients with progressive prostate cancer. The accumulation and location of FDHT activity will be assessed on a site by site basis and correlated with radionuclide bone scan, CT and MRI.
Oncology